Anti-Human SIRPA Therapeutic Antibody Fab Fragment (KWAR23)
Recombinant monoclonal antibody specifically binds to SIRPĪ± and can block the interaction of CD47 on one cell with SIRPĪ± on a phagocytic cell. The antibody can be potentially used in treating mice engrafted with a wide range of human cancers, from leukemias to solid tumors.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-453CT-F(E) |
Pricing | Inquiry |
Host | Humanized |
Target | SIRPA |
Species Reactivity | Human |
Type | Humanized antibody |
Applications | Used for immunoassay techniques such as: Western Blot; Enzyme-linked Immunosorbent Assay |